CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and ...

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Zydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes ...

The plaintiffs argue federal law lets employers structure medicine benefits in ways the 2019 state law threatens.

A state law that went into effect this week aims to regulate the role of third-party pharmacy benefit managers, who many say ...

Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...

United Natural Foods Inc., buoyed by the turnaround plan it began in 2023, saw the biggest lift in value last year among ...

The stock price of Zydus Lifesciences surged over 5 per cent in the Tuesday trading session after the drugmaker’s wholly ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...

Zydus Lifesciences has partnered with CVS Caremark to add its diabetes medications, Zituvio, Zituvimet, and Zituvimet XR, to ...